Trials / Completed
CompletedNCT02344940
Safety of Toremifene and Tamoxifen Therapy in Premenopausal Patients With Operable Breast Cancer
Safety of Toremifene and Tamoxifen Therapy in Premenopausal Patients With Operable Breast Cancer: A Randomized, Controlled, Prospective, Observational Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 104 (actual)
- Sponsor
- Shanghai Jiao Tong University School of Medicine · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To compare the safety of toremifene and tamoxifen therapy in premenopausal patients with operable breast cancer by monitoring gynecological abnormality,blood lipid level,hepatic abnormality,estrogen level and perimenopausal symptoms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Toremifene | patients will take toremifene 60 mg qd. |
| DRUG | Tamoxifen | patients will take tamoxifen 10 mg bid. |
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2018-08-01
- Completion
- 2018-08-01
- First posted
- 2015-01-26
- Last updated
- 2019-09-24
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02344940. Inclusion in this directory is not an endorsement.